vs
Side-by-side financial comparison of Frontdoor, Inc. (FTDR) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
Frontdoor, Inc. is the larger business by last-quarter revenue ($451.0M vs $384.8M, roughly 1.2× P3 Health Partners Inc.). Frontdoor, Inc. runs the higher net margin — 9.1% vs -19.6%, a 28.7% gap on every dollar of revenue. On growth, Frontdoor, Inc. posted the faster year-over-year revenue change (5.9% vs 3.8%). Over the past eight quarters, P3 Health Partners Inc.'s revenue compounded faster (-0.5% CAGR vs -8.8%).
Frontdoor, Inc. operates a leading U.S.-focused home services and protection platform. It offers customizable home warranty plans covering repairs and replacements for household appliances, HVAC, plumbing, and electrical systems, plus on-demand access to a network of pre-vetted local service professionals for residential maintenance and repairs.
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
FTDR vs PIII — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $451.0M | $384.8M |
| Net Profit | $41.0M | $-75.5M |
| Gross Margin | 55.0% | — |
| Operating Margin | — | -40.0% |
| Net Margin | 9.1% | -19.6% |
| Revenue YoY | 5.9% | 3.8% |
| Net Profit YoY | 10.8% | -28.8% |
| EPS (diluted) | $0.57 | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $451.0M | — | ||
| Q4 25 | $432.0M | $384.8M | ||
| Q3 25 | $618.0M | $345.3M | ||
| Q2 25 | $617.0M | $355.8M | ||
| Q1 25 | $426.0M | $373.2M | ||
| Q4 24 | $383.0M | $370.7M | ||
| Q3 24 | $540.0M | $362.1M | ||
| Q2 24 | $542.0M | $379.2M |
| Q1 26 | $41.0M | — | ||
| Q4 25 | $1.0M | $-75.5M | ||
| Q3 25 | $106.0M | $-31.6M | ||
| Q2 25 | $111.0M | $-20.4M | ||
| Q1 25 | $37.0M | $-20.5M | ||
| Q4 24 | $9.0M | $-58.6M | ||
| Q3 24 | $100.0M | $-46.5M | ||
| Q2 24 | $92.0M | $-12.0M |
| Q1 26 | 55.0% | — | ||
| Q4 25 | 49.3% | — | ||
| Q3 25 | 57.1% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 55.2% | — | ||
| Q4 24 | 48.0% | — | ||
| Q3 24 | 56.7% | — | ||
| Q2 24 | 56.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | -40.0% | ||
| Q3 25 | 23.0% | -12.8% | ||
| Q2 25 | 23.7% | -9.6% | ||
| Q1 25 | 11.3% | -10.2% | ||
| Q4 24 | 1.6% | -37.4% | ||
| Q3 24 | 24.8% | -29.5% | ||
| Q2 24 | 22.9% | -8.3% |
| Q1 26 | 9.1% | — | ||
| Q4 25 | 0.2% | -19.6% | ||
| Q3 25 | 17.2% | -9.1% | ||
| Q2 25 | 18.0% | -5.7% | ||
| Q1 25 | 8.7% | -5.5% | ||
| Q4 24 | 2.3% | -15.8% | ||
| Q3 24 | 18.5% | -12.8% | ||
| Q2 24 | 17.0% | -3.2% |
| Q1 26 | $0.57 | — | ||
| Q4 25 | $0.03 | $-23.08 | ||
| Q3 25 | $1.42 | $-9.67 | ||
| Q2 25 | $1.48 | $-6.23 | ||
| Q1 25 | $0.49 | $-6.28 | ||
| Q4 24 | $0.10 | $-23.13 | ||
| Q3 24 | $1.30 | $-15.70 | ||
| Q2 24 | $1.18 | $-7.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $603.0M | $25.0M |
| Total DebtLower is stronger | $1.2B | $228.4M |
| Stockholders' EquityBook value | $230.0M | $-155.2M |
| Total Assets | $2.2B | $656.6M |
| Debt / EquityLower = less leverage | 5.07× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $603.0M | — | ||
| Q4 25 | $566.0M | $25.0M | ||
| Q3 25 | $563.0M | $37.7M | ||
| Q2 25 | $562.0M | $38.6M | ||
| Q1 25 | $506.0M | $40.1M | ||
| Q4 24 | $436.0M | $38.8M | ||
| Q3 24 | $375.0M | $63.0M | ||
| Q2 24 | $419.0M | $73.1M |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.1B | $228.4M | ||
| Q3 25 | $1.2B | $252.8M | ||
| Q2 25 | $1.2B | $182.0M | ||
| Q1 25 | $1.2B | $171.1M | ||
| Q4 24 | $1.2B | $108.9M | ||
| Q3 24 | $565.0M | $133.2M | ||
| Q2 24 | $569.0M | $133.1M |
| Q1 26 | $230.0M | — | ||
| Q4 25 | $242.0M | $-155.2M | ||
| Q3 25 | $316.0M | $-18.7M | ||
| Q2 25 | $254.0M | $44.5M | ||
| Q1 25 | $198.0M | $63.3M | ||
| Q4 24 | $239.0M | $75.9M | ||
| Q3 24 | $261.0M | $120.5M | ||
| Q2 24 | $214.0M | $166.8M |
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.1B | $656.6M | ||
| Q3 25 | $2.2B | $683.6M | ||
| Q2 25 | $2.2B | $731.6M | ||
| Q1 25 | $2.1B | $783.9M | ||
| Q4 24 | $2.1B | $783.4M | ||
| Q3 24 | $1.2B | $833.3M | ||
| Q2 24 | $1.2B | $892.8M |
| Q1 26 | 5.07× | — | ||
| Q4 25 | 4.73× | — | ||
| Q3 25 | 3.64× | — | ||
| Q2 25 | 4.56× | 4.09× | ||
| Q1 25 | 5.88× | 2.71× | ||
| Q4 24 | 4.90× | 1.43× | ||
| Q3 24 | 2.16× | 1.11× | ||
| Q2 24 | 2.66× | 0.80× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-25.7M |
| Free Cash FlowOCF − Capex | $114.0M | — |
| FCF MarginFCF / Revenue | 25.3% | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $387.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $101.0M | $-25.7M | ||
| Q3 25 | $64.0M | $-15.4M | ||
| Q2 25 | $127.0M | $-16.6M | ||
| Q1 25 | $124.0M | $-33.5M | ||
| Q4 24 | $58.0M | $-57.2M | ||
| Q3 24 | $25.0M | $-22.6M | ||
| Q2 24 | $103.0M | $-10.2M |
| Q1 26 | $114.0M | — | ||
| Q4 25 | $95.0M | — | ||
| Q3 25 | $58.0M | — | ||
| Q2 25 | $120.0M | — | ||
| Q1 25 | $117.0M | — | ||
| Q4 24 | $50.0M | — | ||
| Q3 24 | $16.0M | — | ||
| Q2 24 | $91.0M | — |
| Q1 26 | 25.3% | — | ||
| Q4 25 | 22.0% | — | ||
| Q3 25 | 9.4% | — | ||
| Q2 25 | 19.4% | — | ||
| Q1 25 | 27.5% | — | ||
| Q4 24 | 13.1% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 16.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 2.1% | 0.0% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 2.2% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 101.00× | — | ||
| Q3 25 | 0.60× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 3.35× | — | ||
| Q4 24 | 6.44× | — | ||
| Q3 24 | 0.25× | — | ||
| Q2 24 | 1.12× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FTDR
Segment breakdown not available.
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
